Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary Matrix-M adjuvant technology for use in up to two disease areas. The ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...
Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...
PageIndex, a new open-source framework, achieves 98.7% accuracy on complex document retrieval by using tree search instead of ...
Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...
Mix, match and morph both audio and CV with ease, using ADDAC’s matrix mixer ...
In the dynamic environment of small to medium enterprises and startups, leaders often face a barrage of tasks demanding immediate attention. The Eisenhower Matrix, a strategic prioritization tool, ...
Aroa Biosurgery has reaffirmed its FY26 guidance, signalling that results are likely to land at the upper end of expectations ...
WOBURN, MA, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Powered by AFA‑enabled workflows that deliver ...
As of Friday, February 06, Kopin Corporation’s KOPN share price has surged by 12.21%, which has investors questioning if this ...